Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ahronheim, Judith C.
1996.
Nutrition and Hydration in the Terminal Patient.
Clinics in Geriatric Medicine,
Vol. 12,
Issue. 2,
p.
379.
Tison, F.
Wiart, L.
Guatterie, M.
Fouillet, N.
Lozano, V.
Henry, P.
and
Barat, M.
1996.
Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease.
Movement Disorders,
Vol. 11,
Issue. 6,
p.
729.
Fuh, Jong-Ling
Lee, Rheun-Chuan
Wang, Shuu-Jiun
Lin, Cheng-Huai
Wang, Pei-Ning
Chiang, Jen-Huey
and
Liu, Hsiu-Chih
1997.
Swallowing difficulty in Parkinson's disease.
Clinical Neurology and Neurosurgery,
Vol. 99,
Issue. 2,
p.
106.
Wallace, Karen L.
Middleton, Sue
and
Cook, Ian J.
2000.
Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia.
Gastroenterology,
Vol. 118,
Issue. 4,
p.
678.
Pfeiffer, Ronald F
2003.
Gastrointestinal dysfunction in Parkinson's disease.
The Lancet Neurology,
Vol. 2,
Issue. 2,
p.
107.
Bryant, Phillip R
Geis, Carolyn C
Moroz, Alex
O’Neill, Bryan J
and
Bogey, Ross A
2004.
Stroke and neurodegenerative disorders. 4. neurodegenerative disorders11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors(s) or upon any organization with which the author(s) is/are associated..
Archives of Physical Medicine and Rehabilitation,
Vol. 85,
Issue. ,
p.
21.
Monte, Francisca Sueli
da Silva‐Júnior, Francisco Pereira
Braga‐Neto, Pedro
Nobre e Souza, Miguel Ângelo
and
Sales de Bruin, Veralice Meireles
2005.
Swallowing abnormalities and dyskinesia in Parkinson's disease.
Movement Disorders,
Vol. 20,
Issue. 4,
p.
457.
Badrising, U. A.
Maat-Schieman, M. L. C.
Houwelingen, J. C.
Doorn, P. A.
Duinen, S. G.
Engelen, B. G. M.
Faber, C. G.
Hoogendijk, J. E.
Jager, A. E.
Koehler, P. J.
Visser, M.
Verschuuren, J. J. G. M.
and
Wintzen, A. R.
2005.
Inclusion body myositis.
Journal of Neurology,
Vol. 252,
Issue. 12,
p.
1448.
Kaufmann, Horacio
and
Goldstein, David S.
2007.
AUTONOMIC FAILURE IN NEURODEGENERATIVE DISORDERS.
CONTINUUM: Lifelong Learning in Neurology,
Vol. 13,
Issue. ,
p.
111.
Kaufmann, Horacio
and
Goldstein, David S.
2007.
Parkinson's Disease and Related Disorders, Part I.
Vol. 83,
Issue. ,
p.
343.
Tjaden, Kris
2008.
Speech and Swallowing in Parkinson's Disease.
Topics in Geriatric Rehabilitation,
Vol. 24,
Issue. 2,
p.
115.
Cox, F. M.
Verschuuren, J. J.
Verbist, B. M.
Niks, E. H.
Wintzen, A. R.
and
Badrising, U. A.
2009.
Detecting dysphagia in inclusion body myositis.
Journal of Neurology,
Vol. 256,
Issue. 12,
p.
2009.
Clarke, C. E.
Gullaksen, E.
Macdonald, S.
and
Lowe, F.
2009.
Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson's disease.
Acta Neurologica Scandinavica,
Vol. 97,
Issue. 1,
p.
27.
Regan, Julie
Walshe, Margaret
and
Tobin, W. Oliver
2010.
Immediate Effects of Thermal–Tactile Stimulation on Timing of Swallow in Idiopathic Parkinson’s Disease.
Dysphagia,
Vol. 25,
Issue. 3,
p.
207.
Cox, Fieke M.
Titulaer, Maarten J.
Sont, Jacob K.
Wintzen, Axel R.
Verschuuren, Jan J. G. M.
and
Badrising, Umesh A.
2011.
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.
Brain,
Vol. 134,
Issue. 11,
p.
3167.
Pfeiffer, Ronald F.
2011.
Parkinson's Disease.
p.
257.
Heijnen, B. J.
Speyer, R.
Baijens, L. W. J.
and
Bogaardt, H. C. A.
2012.
Neuromuscular Electrical Stimulation Versus Traditional Therapy in Patients with Parkinson’s Disease and Oropharyngeal Dysphagia: Effects on Quality of Life.
Dysphagia,
Vol. 27,
Issue. 3,
p.
336.
Kalf, J.G.
de Swart, B.J.M.
Bloem, B.R.
and
Munneke, M.
2012.
Prevalence of oropharyngeal dysphagia in Parkinson’s disease: A meta-analysis.
Parkinsonism & Related Disorders,
Vol. 18,
Issue. 4,
p.
311.
Kaufmann, Horacio
and
Goldstein, David S.
2013.
Autonomic Nervous System.
Vol. 117,
Issue. ,
p.
259.
JG, Kalf
2013.
Management of Dysphagia and Drooling in Patients With Parkinson’s Disease.
Neurodegenerative Disease Management,
Vol. 3,
Issue. 1,
p.
71.